Financial Results for the Fiscal Year Ended March 31, 2011

May 11, 2011

Name of listed company: TERUMO CORPORATION
Exchange where listed: TSE
Location of headquarters (prefecture): Tokyo( URL http://www.terumo.com/ )Company code number: 4543
Representative:
Yutaro Shintaku, Representative Director and President
Please address all communications to:
Tetsuya Kumei, General Manager, Corporate Communication Dept.
Phone: +81 / 3-3217 - 6550
Adoption of U.S. accounting standards [Yes/No]: No

1. Consolidated Financial Highlights for the Year Ended March 2011
(From April 1, 2010 to March 31, 2011)(1) Consolidated financial results(Note: The amounts shown below ignore values of less than a million yen)

Net sales

Operating income(Millions of yen)

Year ended March, 2011
Year ended March, 2010
(Notes) Comprehensive income:

328,214316,009% (Millions of yen)

3.9
4.4

% (Millions of yen)

62,60663,282

March 2011: 24,454million yen (-45.7%)

Net income

Ordinary income

(1.1)
17.1

% (Millions of yen)

56,90363,611(10.5)
21.0

Net income per Ordinary
stockholders' income per
equitytotal assets

Operatingincome per
Net sales

Net income per share,
fully diluted

(Yen)

(Yen)

%

%

%

170.30214.44

-

9.9
13.7

13.5
15.8

19.1
20.0

(Notes) Equity in earnings of affiliates:
March 2011: 81million yen(20.6)
10.4

March 2010: 45,067million yen (-%)

Net income per share
Year ended March, 2011
Year ended March, 2010%

32,33840,721March 2010: 81million yen(2) Consolidated financial position
Total assets
As at March 31, 2011
As at March 31, 2010

Net assets(Millions of yen)

(Millions of yen)

420,037
425,507335,456
317,139

Equity ratio

Net assets per share

%

(Yen)

79.8
74.5

1,765.32
1,668.93(Notes) Number of shares outstanding at end of period (consolidated):
March 2011: 189,881,334 shares March 2010: 189,895,067 shares(3) Consolidated statements of cash flows
Cash flows fromoperating activities
Year ended March, 2011
Year ended March, 2010

Cash flows frominvesting activities

Cash flows fromfinancing activities

Cash and cash equivalents,
end of period(Millions of yen)

(Millions of yen)

(Millions of yen)

(Millions of yen)

46,82867,352(18,989)(25,273)(26,416)(11,487)

82,66084,877

2.Dividends

Year ended March, 2010
Year ended March, 2011
Year ending March, 2012 (forecast)at 1st half end

Cash dividends per shareat fiscal year end

total

(Ｙen)

(Ｙen)

(Ｙen)

16.00
16.00
17.00

16.00
18.00
17.00

32.00
34.00
34.00

3. Consolidated Forecasts for the Year Ending March 2012 (From April 1, 2011 to March 31, 2012)
Net sales

Operating income(Millions of yen)Half year ending September, 2011

Year ending March, 2012

157,000
332,000% (Millions of yen)

(4.2)
1.2

Ordinary income% (Millions of yen)

30,00065,000(8.3)
3.8

29,00063,000Net income% (Millions of yen)

2.9
10.7

18,50040,000

%

0.7
23.7

(N.B.) Estimated earnings per share (full year): 210.66 yen(Notes) Above forecasts DO NOT include performance of Caridian BCT and Harvest.
The forecast takes straight-line method of tangible noncurrent assets due to unify all group companies.

Among the information that Terumo discloses, forecasts of financial performance on future projections contain potential risks anduncertainty since these are forecasts on projections made by Terumo based on limited information available at the moment of
disclosure. Accordingly, it should be noted that actual results may differ from those forecasts on projections due to various factors.
Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuationsof foreign exchange rates, and state of competition.

14. Financial Statements(1) Consolidated balance sheet
As at March 31, 2010

As at March 31, 2011

AmountAmount(Assets)%

I Current assets

230,43154.2%

ChangesAmount%236,510

56.3%

%
6,078

Cash and deposits

90,102

83,794(6,307)

Noteｓ and accounts receivable-trade

71,79876,4804,681

Marchandise and finished goods

34,18036,152

1,972

Work in process

6,143

5,869

(273)

Raw material and supplies

14,741

15,651

909

Deferred tax assets

9,086

7,797

(1,289)

6,084

6,084
334

Derivatives

-

Other

5,071

5,406

Allowance for doubtful accounts

(693)

(726)

2.6%

(32)

II Noncurrent assets

195,07645.8%

183,52743.7%(11,548)(5.9%)

1. Property, plant and equipment

114,03026.8%

113,059

26.9%

(971)

(0.9%)

Buildings and structures

45,53345,052(480)

Machinery, equipment and vehicles

29,34529,861516

Land

20,285

20,227

(58)

665

950

285

11,941

10,442(1,498)

Lease assets
Construction in progress
Other

6,259

2. Intangible assets

30,1296,524
7.1%

26,728Goodwill

22,98920,191

Other

7,140

6,537

3. Investments and other assets

50,915

11.9%

43,739264
6.4%(3,401)(2,798)
(603)

10.4%

(7,176)

Investment securities

38,86828,895

Deferred tax assets

6,614

8,136

1,522

Other

5,433

6,706

1,273

Total assets

425,5072

100.0%

420,037(11.3%)(14.1%)(9,972)100.0%(5,469)(1.3%)

As at March 31, 2010

As at March 31, 2011

AmountAmount(Liabilities)
I%

Current liabilities

99,731

Notes and accounts payable-trade27,367

Short-term loans payable

20,000

Lease obligations
Income taxes payable%
78,84618.8%

30,711%(20,885)-(20,000)

219

294

74

12,994

6,297(6,696)

7

123

115

Provision for bonuses

4,898

5,001

102

161

145

(16)

Provision for loss on disaster-

Notes and accounts payable-facilities

8,031

Asset retirement obligations

-

Other

26,049Noncurrent liabilities

8,636

2.0%

351

351

5,749

(2,281)560

560

29,611

3,561

5,734

1.3%

(2,901)

Lease obligations

463

636

Deferred tax liabilities

40

378

337

4,677

1,082

(3,594)

Provision for retirement benefits
Provision for directors' retirement benefits

658

Asset retirement obligations-(20.9%)

3,343

Deferred tax liabilities

Provision for directors' bonuses

II

23.5%

ChangesAmount(33.6%)

172

586

(72)

991

991

2,060

(735)

Other

2,795

Total liabilities

108,367

25.5%

84,581

20.1%(23,786)(21.9%)

I

Shareholders' equity

337,633

79.3%

363,832

86.6%

26,199

7.8%

Capital stock

38,716

38,716

Capital surplus

59,03059,030Retained earnings

316,703342,965

II

Treasury stock(76,817)

Accumulated other comprehensive income(20,711)

Valuation difference on available-for-sale securities

Foreign currency translation adjustment
III Minority interests

26,262(76,879)(4.9%)

2,335

Deferred gains or losses on hedges-(28,630)(62)(6.8%)(1,919)(7,919)

-

3,611

3,611

(23,046)(30,322)(7,275)

218

0.1%

254

38.2%

(4,255)

0.1%

36

16.6%

Total net assets

317,13974.5%

335,45679.9%

18,316

5.8%

Total liabilities, net assets

425,507100.0%

420,037

100.0%(5,469)(1.3%)

3

(2) Consolidated statement of income
For the year ended

For the year ended

March 31, 2010

March 31, 2011

AmountChangesAmountAmount%%%I

Net sales

316,009100.0%

328,214100.0%

12,205

3.9%

II

Cost of sales

149,65947.4%

157,416

48.0%

7,757

5.2%

Gross profit

166,35052.6%

170,798

52.0%

4,448

2.7%

103,067

32.6%

108,191

32.9%

5,123

5.0%

63,28220.0%

62,606

19.1%

(675)

(1.1%)(20)(1.3%)III Selling, general and administrative expenses
Operating income
IV Non-operating income

V

Interest income

388

269

(118)

Dividends income

333

458

124

Royalty income

142

142

(0)

Equity in earnings of affiliates

81

81

Incentive income

169

Other

495

(0)
-

1,611

0.5%

638

(169)
1,590

143

Non-operating expenses
Interest expenses

169

54

Sales discounts

574

573

(1)

Foreign exchange losses

84

4,428

4,343

Loss on disposal of inventories

159

654

494

Other

293

Ordinary income

1,281

0.4%

63,611

20.1%

(115)

1,583

7,293
56,903

1,290
17.3%

6,011

469.1%(6,708)(10.5%)

498

7,377.6%

VI Extraordinary income
Gain on sales of noncurrent assets

3

10

6

Reversal of allowance for debtful accounts

3

0

(2)

Gain on contribution of securities to retirement benefit trust

-

6

0.0%

494

505

0.2%

494

Ⅶ Extraordinary expenses
Loss on disposal of noncurrent assets

189

2,257

Loss on valuation of investment securities

1

19

Impairment loss

20

Loss on disaster
Directors' retirement benefits-

Settlement package-

Income before income taxes
Income taxes-current

22,432

Income taxes-deferred

169

555

15
212

0.0%

63,40620.1%

22,601

7.2%

3,000

15
5,848

1.8%

51,56015.7%

19,156

5.8%

18,992

-

4

(20)

555

Income before minority interests

Net income

17
-

-

Minority interests income

2,067

164

3,000

5,636

2,654.5%(11,845)(18.7%)(3,444)(15.2%)(3,440)(4)-

32,403

9.9%

-

-

82

0.0%

64

0.0%

(18)

(21.9%)

40,721

12.9%

32,3389.9%(8,383)(20.6%)

(3) Consolidated statement of comprehensive income
For the year ended

For the year ended

March 31, 2010

March 31, 2011

AmountAmountAmount%I

Income before minority interests

II

Other comprehensive income
Valuation difference on available-for-sale securities

Changes%-- 32,403-(4,255)100.0%%--

Deferred gains or losses on hedges

-

3,611

-

Foreign currency translation adjustments-(7,303)-

Share of other comprehensive income of associates
accounted for using equity method

-

-

-

-

Shareholders of Terumo Corporation
Minority interests

Comprehensive income(1)-(7,949)24.5%-

24,454

-

-

-

-

-

-

-

75.5%

-

-

24,418

75.4%

-

-

36

0.1%

-

-

Attributable to:5(4) Statement of changes in net assets(Millions of yen)
Shareholders' equity

Year ended March 2010
Beginning of period
Changes during this fiscal year
Dividends from surplus
Net income
Purchase of treasury stock
Changes of items other than shareholders' equity (net)Total changes during this fiscal year
Ending of period

Capital stock
38,716

Capital surplus

Retained earnings

59,030282,058(76,800)

Shareholders'equity total
303,005(17)(6,076)
40,721(17)(17)(76,817)

34,628337,633

Treasury stock(6,076)
40,721

38,716-

34,645
316,703

59,030

Valuation and translation adjustments
Valuation difference on
Foreign currency
available-for-sale securities
translation adjustments
Year ended March 2010
Beginning of period
Changes during this fiscal year
Dividends from surplus
Net income
Purchase of treasury stock
Changes of items other than shareholders' equity (net)Total changes during this fiscal year
Ending of period(5,118)

7,454
7,454
2,335

(19,823)

Valuation andMinority Net assets
Translationinterests
total
adjustments total(24,942)104
278,166(3,223)(3,223)(23,046)(6,076)
40,721(17)
4,344
38,972
317,139

4,230
4,230
(20,711)

114
114
218

(Millions of yen)
Shareholders' equity
Year ended March 2011
Beginning of period
Changes during this fiscal year
Dividends from surplus
Net income
Purchase of treasury stock
Changes of items other than shareholders' equity (net)Total changes during this fiscal year
Ending of period

Capital stock
38,716

Capital surplus

Retained earnings

59,030316,703(76,817)

Shareholders'equity total
337,633(62)(6,076)32,338(62)(62)(76,879)

26,199363,832

Treasury stock(6,076)32,338-38,71659,030

Valuation difference on
available-for-sale securities
Year ended March 2011
Beginning of period
Changes during this fiscal year
Dividends from surplus
Net income
Purchase of treasury stock
Changes of items other than shareholders' equity (net)Total changes during this fiscal year
Ending of period

26,262342,965

2,335

Accumulated other compehensive income
Deferred gains or losses
Foreign currencytranslation
on hedges
adjustments(23,046)(4,255)(4,255)(1,919)

3,611
3,611
3,611

(7,275)(7,275)(30,322)

Accumulated
other comprehensive
income total(20,711)

Minority
interests
218

Net assets
total
317,13936
36
254(6,076)32,338(62)(7,882)
18,316335,456(7,919)(7,919)(28,630)

Additional Information(Adoption of Accounting Standard for Presentation of Comprehensive Income)
Commencing in the year ended March 31, 2011, the Company and its consolidated domestic subsidiaries adopted the ASBJ Statement No. 25, Accounting Standard for Presentation ofComprehensive Income, issued by the ASBJ on June 30, 2010. The amounts presented as "Accumulated other comprehensive income" and "Accumulated other comprehensive income total"in the consolidated financial statements for the year ended March 31, 2010 represent amounts of "Valuation and translation adjustments" and "Valuation and translation adjustments total",
respectively.

6(5) Consolidated statements of cash flows(Millions of yen)

For the year ended

For the year ended

March 31, 2010

March 31, 2011

AmountAmountI Net cash provided by (used in) operating activities
Income before income taxes

63,406

51,560Depreciation and amortization

18,186

18,812

Impairment loss
Amortization of goodwill
Equity in (earnings) losses of affiliates

20

-

1,723

1,580

(81)

(81)

1,242

(3,555)

Increase(decrease) in provision for directors' retirement benefits

(1)

(72)

Increase(decrease) in allowance for doubtful accounts

(30)

48

Increase(decrease) in provision for retirement benefits

Increase(decrease) in provision for directors' bonuses

(11)

(16)

Interest and dividends income

(722)

(727)

Incentive income

(169)

-

Interest expenses

169

54

Foreign exchange losses (gains)

284

2,535

Settlement package

-

3,000

Loss on disaster

-

555

189

2,257

Loss (gain) on sales of noncurrent assets

(3)

(10)

Loss (gain) on valuation of investment securities

1
-

19
(494)

Loss (gain ) on disposal of noncurrent assets

Loss (gain) on contribution of securities to employees' retirement
benefits trust
Transfer of securities to retirement benefit trust

-

3,200

Decrease (increase) in notes and accounts receivable-trade(5,855)(6,530)Decrease (increase) in inventories(1,403)(4,800)

Increase (decrease) in trade payable

(395)

3,213

Other, net

4,831

2,986

81,38273,534

Interest and dividends income received

924

916

Incentive received

169-

Interest expenses paid

(179)

(60)

-

(1,500)(14,945)(26,061)

67,352

46,828(16,578)(2,723)

Subtotal

Settlement package paid
Income taxes paid
Net cash provided by (used in) operating activities
II Net cash provided by (used in) investment activities
Payments into time deposits
Proceeds from withdrawal of time deposits

13,336

6,420

Purchase of property, plant and equipment(18,440)(21,561)

Proceeds from sales of property, plant and equipment

14

44

Purchase of intangible assets(1,276)(672)

Purchase of investment securities(2,908)

(12)

100

-

Proceeds from redemption of investment securities
Other, net
Net cash provided by (used in) investment activities

480

(482)

(25,273)(18,989)(5,190)(20,000)

(17)

(62)

III Net cash provided by (used in) finacing activities
Net increase (decrease) in short-term loans payable
Purchase of treasury stock
Repayments of financial lease obligations

(204)

(277)

(6,076)(6,076)(11,487)(26,416)(780)(3,639)V Net increase(decrease) in cash and cash equivalents

29,810(2,217)

VI Cash and cash equivalents at beginning of period

55,06784,877

Ⅶ Cash and cash equivalents at end of period

84,877

82,660Cash dividends paid
Net cash provided by (used in) finacing activities
IV Effect of exchange rate changes on cash and cash equivalents

7(6)Notes
Significant accounting policies in preparing the consolidated financial statements

Accounting periods of consolidated subsidiaries
The year end consolidated balance sheet date is March 31. Among the consolidated subsidiaries,
Terumo Medical Products (Hangzhou) Co., Ltd., Changchun Terumo Medical Products Co., Ltd.,
Terumo (Thailand) Co., Ltd., Terumo Vietnam Co., Ltd., and PT. Terumo Indonesia have a year end
balance sheet date different from the year end consolidated balance sheet date, all of which are December 31.
Commencing in the year ended March 31, 2011, for these 5 companies, financial statements preparedfor consolidation as of the consolidated balance sheet date are used to supplement the companies' statutoryfinancial statements.
Accordingly, for these companies, the consolidated operating results for the year ended March 31, 2011
consisted of 15 months of operations from January 1, 2010 to March 31, 2011. The effects of this change on
the consolidated statement of operations for the year ended March 31, 2011 were to increase sales
by 1,923 million yen, increase operating income by 970 million yen, increase ordinary income by 916 million yen
and increase net income by 685 million yen respectively. Also, the effects of this change on segment information
are discussed in the applicable section of the footnotes to the consolidated financial statements.

Accounting Changes and Adoption of New Accounting Standards(Adoption of Accounting Standards for Asset Retirement Obligations)
Commencing in the year ended March 31, 2011, the Company and its consolidated domestic subsidiaries adopted
the ASBJ Statement No. 18 Accounting Standard for Asset Retirement Obligations and the ASBJ Guidance No. 21
Guidance on Accounting Standard for Asset Retirement Obligations, both issued by the ASBJ on March 31, 2008.
The effects of adopting these standards on the consolidated statement of operations for the year ended
March 31, 2011

Changes in Financial Statement Presentation(Consolidated statement of balance sheet)
Through the year ended March 31, 2010, balance from derivative transactions, which amounted to 109 million yen
in the year ended March 31, 2010, was included in “Other” in current asset. However, commencing in the year
ended March 31, 2011, the balance is separately presented as "Derivatives" due to an increase in materiality.

(Consolidated statement of income)
Commencing in the year ended March 31, 2011, the Company adopted the Cabinet Office Ordinance No. 5,
Cabinet Office Ordinance Revising Some Portions of the Regulations for Financial Statements, dated March 24,
2009, based on the ASBJ Statement No. 22 Accounting Standard for Consolidated Financial Statements,
issued by the ASBJ on December 26, 2008. As a result, "Income before minority interests" is presented in
the consolidated statement of operations for the year ended March 31, 2011.

Relating to consolidated balance sheet
I Ending balance of accumulated depreciation of tangibel assets(Millions of yen)March 31, 2010

March 31, 2011

220,213228,584

Accumulated depreciation of tangible assets

II Ending balance of investment in securities to nonconsolidated subsidiaries and related companies
March 31, 2010

March 31, 2011

2,513

2,405

Investment in securities

Relating to consolidated statement of income
I Main items among selling, general and administrative expenses(Millions of yen)

Year ended
March 31, 2010

Year ended
March 31, 2011

Promotion and advertisement fee

11,011

Transportation and packaging cost

9,043

9,632

Salaries

24,97525,357

Bonuses

3,137

3,409

Provision for bonuses

2,302

2,345

Pension

2,703

2,517

R&D expenditures

17,527

20,355

Depreciation and amortisation

3,344

3,143

Provision for directors' bonuses

161

145

II R&D expenditures

10,463

Year ended
March 31, 2010

Year ended
March 31, 2011

17,527

20,355

III Itemized statement of gain on sales of noncurrent assets
Year ended
March 31, 2010

Machinery and transportation equipment
Other tangible noncurrent assets
Total gains on sales of noncurrent assets

Year ended
March 31, 2011

3
0
3

8
1
10

8

IV Itemized statement of loss on disposal of noncurrent assets
Year ended
March 31, 2010

Buildings and structures
Machinery and transportation equipment
Other tangible noncurrent assets
Total loss on disposal of noncurrent assets

Year ended
March 31, 2011

35
126
26
189

1,878
313
65
2,257

V Impairment loss

Location
Application
Assortment
AmountImpairment amountYear ended
March 31, 2010

Year ended
March 31, 2011

USA・EU
Equipment (idle asset)
Machinery andtransportation
20
20

-

Relating to consolidated statement of comprehensive income
Itemized statement of comprehensive income and other comprehensive income for the fiscal year ended March, 2010
I Comprehensive income
Comprehensive income attributable to shareholders of Terumo Corporation
Comprehensive income attributable to minority interests
Total(Millions of yen)
44,953114
45,067

II Other comprehensive income
Valuation difference on available-for-sale securities
Foreign currency translation adjustments
Share of other comprehensive income of associates accounted for using equity method
Total

7,454
(3,191)0
4,263

Relating to consolidated statement of changes in net assets
I Year ended March, 2010
i Category and total number of issued stock and treasury stock(Thousand)Increase during
this fiscal period

Beginning balanceIssued stock : common stock
210,876
Treasury stock : common stock
20,977Note : The increase or treasury stock is from taking up odd stock.

3

Decrease during
this fiscal periodEnding balance-

210,876
20,981ii Items on dividendsa) Delivery of dividends(Resolution)

Category of stock

Dividends Dividends(millions per share
yen)
(yen)

Dividends record date

Effective date

Annual meeting of shareholders
held on June 19, 2009

Common stock

3,038

16

March 31, 2009

June 22, 2009

A board of directors held on October 29, 2009

Common stock

3,038

16

September 30, 2009

December 8, 2009b) Devidends recorded in this fiscal period but effective in the next period(Resolution)
Annual meeting of shareholders
held on June 29, 2010

Category of stock

The
Dividends
Dividends
original
per share(millionscapital of
(yen)
yen)
dividends

Earned3,038 surplus

Common stock

Dividends record date

Effective date

March 31, 2010

June 30, 201016

II Year ended March, 2011i Category and total number of issued stock and treasury stock
Increase during
this fiscal period

Beginning balanceIssued stock : common stock
210,876
Treasury stock : common stock
20,981
Note : The increase or treasury stock is from taking up odd stock.

13

Decrease during
this fiscal periodEnding balance-

210,876
20,994ii Items on dividendsa) Delivery of dividends(Resolution)

Category of stock

Dividends Dividends(millions per share
yen)
(yen)

Dividends record date

Effective date

Annual meeting of shareholders
held on June 29, 2010

Common stock

3,038

16

March 31, 2010

June 30, 2010

A board of directors held on October 28, 2010

Common stock

3,038

16

September 30, 2010

December 7, 2010b) Devidends recorded in this fiscal period but effective in the next period(Resolution)
Annual meeting of shareholders
scheduled for June 29, 2011

Category of stock

The
Dividends
Dividends
original
per share(millionscapital of
(yen)
yen)
dividends

Common stock

Earned3,417 surplus

Dividends record date

Effective date

March 31, 2011

June 30, 201118

Relating to consolidated statement of cash flows
Reconciliation of cash and cash equivalents on the annual consolidated balance sheet(Millions of yen)

Year ended
March 31, 2010

Cash on hand and in banks
Time deposits, bonds and other with original
maturity exceeding a three-month period
Cash and cash equivalents

Year ended
March 31, 2011

90,102(5,224)

83,794(1,133)84,877

82,6609

5. Segment Information[Reportable Segments](1) Fiscal year ended March 31, 2010

(Millions of yen)

General Hospitalbusiness

For the year ended
March 31, 2010

Cardiac &Vascularbusiness

Blood
Transfusionbusiness

Consumer
Healthcare
business

Subtotal

Adjustment

Total

Sales:
Sales to customer

149,668

135,890

23,981

6,456

315,997

11

-

-

-

-

-

-

-

149,668

135,890

23,981

6,456

315,99711

316,009

Internal sales
Sales total

316,009

Segment income (loss)

27,21233,1462,478

194

63,031

250

63,282

Segment assets

141,281

143,712

26,971

5,374

317,339

108,168

425,507

Depreciation and amortization

10,707

6,555

2,022

298

19,582327

19,909Equity in earnings of affiliates
Net increase of tangible andintangible noncurrent assets

-

-

-

-

-

81

81

10,581

7,656

2,704

478

21,420732

22,152Others:

Notes:

1. Segment income is adjusted to be consistent with operating income shown on the
consolidated income statement.
2. Adjustment to segment income (loss), which amounted to 250 million yen, mainly includes
adjustment of transactions between reportable segments.
3. Adjustment to segment assets, which amounted to 108,168 million yen, mainly includes
investments in "Cash and deposit", "Investment securities", "Deferred tax assets" andassets of the Administrative Department.

(2) Fiscal year ended March 31, 2011

(Millions of yen)
For the year ended
March 31, 2011

General Hospitalbusiness

Cardiac &Vascularbusiness

Blood
Transfusionbusiness

Consumer
Healthcare
business

Subtotal

Adjustment

Total

Sales and operating income:Sales to customer

152,786

144,598

24,5494,337

326,272

1,942

-

-

-

-

-

-

-

152,786

144,598

24,5494,337

326,272

1,942

328,214

Internal sales
Sales total

328,214Segment income (loss)

26,36833,9292,956(1,565)61,688918

62,606

Segment assets

142,557

146,159

27,864

4,238

320,819

99,218420,037

Depreciation and amortization

10,330

7,487

1,970

198

19,988404

20,392Equity in earnings of affiliates
Net increase of tangible andintangible noncurrent assets

-

-

-

-

-

81

81

9,736

7,156

2,413

294

19,601

642

20,243

Others:

Notes:

1. Segment income is adjusted to be consistent with operating income shown on the
consolidated income statement.
2. Adjustment to segment income (loss), which amounted to 918 million yen, is the sumof (820) million yen for Inventories, 970 million yen for the change of accounting
period of Terumo's subsidiaries and 767 million yen for others.
3. Adjustment to segment assets, which amouted to 99,218 million yen, mainly includes
investments in"Cash and deposit", "Investments securities", "Deferred tax assets" andassets of the Administrative Department.

(Additional Information)
Beginning with the fiscal year ended March 31, 2011, segment information is presented according to Terumo's management
approach based on Accounting Standard for Disclosures about Segments of an Enterprise and Related Information (ASBJ Statement
No.17, issued March 27, 2009) and Guidance on Accounting Standard for Disclosures about Segments of an Enterprise and RelatedInformation (ASBJ Guidance No.20, issued March 21, 2008).
(Note) Main products belonging to each business segment

Business segments

Main products

General Hospital business
Disposable medical devices
and Medical electronics

Syringes, Needles, Blood collection tubes, Home parenteral nutrition system,
Solution sets, I.V.catheters, Infusion pumps, Syringe pumps, Home oxygen therapy system,
etc.

Pharmaceuticals

I.V.solutions, Nutritious food, Prefilled syringes, CAPD systems, etc.

Diabetes care products

Blood glucose monitoring systems

Cardiac and Vascular business
Interventional systems

Angiographic catheters, PTCA balloon catheters, Coronary stents, Neuro interventionalcoils, etc.

Cardiovascular systems

Oxygenerators, Cardio-pulmonary bypass system, LVA system, etc.

Vascular grafts

Artificial vascular grafts, Stent grafts

Blood Transfusion business

Blood bags, Automated blood processing, etc.

Consumer Healthcare business

Digital Thermometers, Blood pressure monitors, Blood glucose monitors (OTC), etc.

10(Supplemetary Information)[Geographic Segments](1) Fiscal year ended March 31, 2010

(Millions of yen)
For the year ended
March 31, 2010

Japan

EuropeAmericas

Asia and others

Total

Sales

173,91056,59053,776

31,731

316,009

Tangible noncurrent assets

88,951

5,923

6,993

12,162

114,030(2) Fiscal year ended March 31, 2011

(Millions of yen)
For the year ended
March 31, 2011

Japan

EuropeAmericas

Asia and others

Total

Sales

177,132

56,63056,97737,474

328,214

Tangible noncurrent assets

88,71358,888

6,892

11,565

113,059

Notes:

Sales figure of Asia and others includes adjustment for the change ofaccounting period of Terumo's subsidiaries, which amounted to 1,923
million yen.

11